Position in INCY
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$1,696,418
+$387,716 QoQ
Shares Held
18,024
+36.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GATEWAY INVESTMENT ADVISERS LLC holds $101,169,023 across 9 Biotechnology names. INCY ranks #4 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
365,000 | $59,684,800 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
67,121 | $29,972,211 | |
| 3 | MRNA |
Moderna, Inc.
|
146,265 | $7,430,262 | |
| 4 | INCY |
Incyte Corp
This page
|
18,024 | $1,696,418 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,251 | $744,788 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
779 | $601,886 | |
| 7 | TECH |
BIO-TECHNE Corp
|
9,712 | $507,549 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
1,474 | $278,659 |
All Filings in INCY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,696,418 | 18,024 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,308,702 | 13,250 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $772,279 | 9,106 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $594,785 | 8,734 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $534,535 | 8,828 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $311,989 | 4,517 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $259,773 | 3,930 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $260,423 | 4,296 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $204,750 | 3,594 | Shares | Sole | 2024-04-12 | |
| No filing history on record for this holder in this stock. | ||||||